Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FDSXM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,302
Award facts
- Contract value 100% obligated
- $43,301.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $43,301.94 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors. This firm fixed-price delivery order, issued on October 30, 2025, with completion scheduled for October 31, 2025, represents a non-competitive award made under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and moderate-to-severe asthma, making it a specialized pharmaceutical product critical to military and veteran healthcare systems.
This delivery order is issued as a child contract under AmerisourceBergen's comprehensive pharmaceutical prime vendor agreement with DLA Troop Support Medical (SPE2DX), valued at $999 million through December 2026. The prime vendor contract serves as a global procurement vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products, medical devices, and healthcare commodities to support military medical operations worldwide. The company's federal procurement activities reflect its established role as a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through competitive federal procurement processes.
Quick answers
Who was awarded contract SPE2DB26FDSXM?
SPE2DB26FDSXM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FDSXM worth?
The government has obligated $43,302 on SPE2DB26FDSXM.
Is contract SPE2DB26FDSXM an order under another contract?
Yes. SPE2DB26FDSXM is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB26FDSXM competed?
The extent of competition for SPE2DB26FDSXM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award